I see tweedle dee and tweedle dumb are back.
The CRL was issued because the potency assay was incorrectly supported, and the efficacy was not linked to the assay.
We all know for a fact the cells work, look at the mortality data. BEST IN CLASS... by a mile!
MSB has now shown the potency assay supports the efficacy data.
Phase 3 huge success, met the primary end point, massive mortality benefit, and now company has the link between potency and survival, p values all under .05
11, max 12 trading days left
I can't wait to rub approval in their faces.
Not even thinking about the profit... just rubbing it in their faces... and Sorepocket who probably created a new account and is onto another stock shorting right now.
2023 The Final Countdown, page-2139
-
- There are more pages in this discussion • 1,265 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |